Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Stephen Nakrosis Shares of Axogen spiked after hours following the company's announcement a clinical study of its Axoguard Nerve Cap met its primary...
By Sabela Ojea Nurix Therapeutics said the Food and Drug Administration has granted fast-track designation for NX-5948, its treatment for certain types of...
By Denny Jacob TransCode Therapeutics said Michael Dudley, co-founder and chief executive, would retire, part of its restructuring intended to further reduce...
By Chris Wack Theravance Biopharma said results from its Phase 4 study of Yupelri revefenacin inhalation solution failed to meet its primary endpoint....
By Josh Beckerman Innate Pharma's American depositary receipts were recently up 4%, to $2.89, after the Food and Drug Administration lifted a partial...